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A B S T R A C T
Background
Metabolic or mixed (metabolic and respiratory) acidosis are commonly encountered problems in the low birth weight (LBW) infant
after delivery, and they may contribute to mortality and morbidity. Causes for the lactic acidosis are multiple and include maternal,
placental and fetal factors. It is unclear whether metabolic acidaemia in the first 24 hours of life in LBW infants should be corrected by
rapid infusion of alkali.
Objectives
The main objective was to assess the short and long-term effects of the rapid correction of early (first 24 hours) metabolic acidaemia
in LBW (<2500g birth weight) neonates.
Search methods
Searches were undertaken of MEDLINE from February 2004 back to 1966 and the Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library, Issue 1, 2004). The title and abstract of each retrieved study were examined to assess eligibility.
If there was uncertainty, the full paper was examined.
Selection criteria
Types of studies
All randomised controlled trials where short or long term effects of treatment with alkalising agents by rapid infusion were compared
with placebo or no treatment, or where rapid infusion of alkalising agents was compared with slow infusion.
Types of participants
Newborn infants with birth weight <2500g and less than 24 hours of age with proven metabolic acidaemia (on arterial blood gas).
Types of interventions
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Rapid correction of acidaemia with alkalising agents (sodium bicarbonate and/or THAM) given as a bolus over 5 minutes or less
compared with either placebo, no intervention or slow infusion (>5 minutes).
Types of outcome measures
1) maximal oxygen requirement in first 24 hours
2) duration of oxygen therapy
3) need for and duration of assisted ventilation
4) intraventricular haemorrhage and/or periventricular leucomalacia
5) survival to discharge
6) long term survival (to 24 months of age)
7) neurological and developmental outcome at 24 months of age
Data collection and analysis
Each reviewer assessed eligibility, trial quality and extracted data separately, then compared and resolved differences. Study authors were
contacted for additional information if necessary.
Main results
No studies were found meeting the criteria for inclusion in this review.
Authors’ conclusions
There is no evidence available from randomised controlled trials to support or refute the rapid correction of metabolic acidaemia, in
LBW infants in the first 24 hours of life, as compared with slow or no correction.
P L A I N L A N G U A G E S U M M A R Y
Rapid correction of early metabolic acidaemia in comparison with placebo, no intervention or slow correction in LBW infants
Plain language summary will be included with future update.
B A C K G R O U N D
Metabolic or mixed (metabolic and respiratory) acidosis are com-
monly encountered problems in the low birth weight (LBW) in-
fant after delivery, and they may contribute to mortality and mor-
bidity. Lactic acid is the product of anaerobic metabolism which
occurs with perinatal asphyxia and/or hypoxaemia occurring dur-
ing or after birth. Causes for the lactic acidosis are multiple and
include maternal, placental and fetal factors.
Following hypoxaemia, cardiovascular, metabolic and behavioural
responses occur which decrease oxygen demand and redistribute
available oxygen to the brain, heart and adrenal glands. The con-
sequences of these responses include vasoconstriction, inhibition
of spinal reflexes, midbrain activation and increased sympathetic
tone. A shift to the anaerobic metabolic pathway leads to an accu-
mulation of lactic acid. The resulting acidaemia causes a right shift
in the haemoglobin-O2 dissociation curve which further lowers
blood oxygen content. Hypoxaemia and acidosis also contribute
to a high pulmonary vascular resistance which results in a right to
left shunt. Right to left shunts have been demonstrated in infants
born with perinatal asphyxia and respiratory distress syndrome.
Treatments for metabolic acidaemia include the use of alkalising
agents such as sodium bicarbonate or tromethamine (THAM),
and oxygen. The purported benefits of normalising the pH in-
clude a reduction in pulmonary vascular resistance, an increase
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in myocardial contractility, improved hemodynamic responses to
resuscitation with epinephrine and oxygen, and increased sur-
vival (Martin 1993; Preziosi 1993). However, evidence from ran-
domised controlled studies in human infants does not support the
use of sodium bicarbonate to improve mortality or incidence of
intraventricular haemorrhage.
Several studies have raised doubt concerning the benefits of using
alkalising agents during hypoxic lactic acidosis. Although sodium
bicarbonate correctsmetabolic acidosis, its administration can lead
to a transient decrease in intra-myocardial pH, cardiac output
and blood pressure (Graf 1985; Kette 1990). The reason for this
is that correction of metabolic acidosis with an alkalising agent
such as bicarbonate depends on the removal of CO2 and only
functions in an ’open’ system (Ostrea 1972). This is according to
the Henderson-Hasselbalch equation:
H+ + HCO3- <=> H2O + CO2.
Small, stressed babies frequently accumulate CO2 secondary to
respiratory failure (Baum 1975). CO2 crosses the cellular mem-
brane very quickly and thus leads to worsening of intracellular aci-
dosis by shifting the Henderson-Hasselbalch equation to the left.
In addition to this, the administration of a hyperosmolar solution
such as sodium bicarbonate causes changes in serum osmolality.
The resulting fluid shift causes cells, including red blood cells, to
lose water-increasing intracellular ionic strength (Ostrea 1972).
Proteins then become stronger acids and generate additional acid
by releasing protons (Howell 1987). There is also evidence that
especially rapid injection (five minutes or less) of hypertonic so-
lutions of sodium bicarbonate or THAM may be harmful. Rapid
injection may cause increases in intra-vascular volume and venous
pressure with profound effects on the brain including haemor-
rhage or haemorrhagic infarction (Finberg 1977). On the other
hand, studies have shown an association between metabolic aci-
dosis and poor neurodevelopmental outcome (Goldstein 1995,
Skouteli 1988).
The dilemma remains, therefore, of whether metabolic acidaemia
in the first 24 hours of life in LBW infants should be corrected
by rapid infusion of alkali. Our aim is to review the evidence con-
cerning the use of rapid infusion (five minutes or less) of alkalising
agents to treat early (first 24 hours) metabolic acidaemia in LBW
infants.
O B J E C T I V E S
The main objective was to assess the short-term (such as improved
oxygenation as measured by blood gas analysis, oxygen require-
ment, length of ventilation, intracranial haemorrhage andneonatal
survival) and long-term (such as survival and neurodevelopmental
outcome) effects of the rapid correction of early (first 24 hours)
metabolic acidaemia in LBW (<2500g birth weight) neonates.
The two comparisons therefore were:
1. rapid correction vs placebo or nothing
2. rapid vs slow correction
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials where short or long term effects of
treatment with alkalising agents by rapid infusion were compared
with placebo or no treatment, or where rapid infusion of alkalising
agents was compared with slow infusion.
Types of participants
Newborn infants with birth weight <2500g and less than 24 hours
of age with proven metabolic acidaemia on arterial blood gas.
Metabolic acidaemia was defined as pH <7.25 with a PaCO2 of
<45 mm Hg.
Types of interventions
Rapid correction (bolus or rapid infusion over 5 minutes or less)
of early metabolic acidaemia using sodium bicarbonate or THAM
was compared with either: 1) placebo or no correction or 2) a slow
infusion (> 5 minutes) of alkali.
Types of outcome measures
1) maximal oxygen requirement in first 24 hours
2) duration of oxygen therapy (hours or days)
3) need for and duration of assisted ventilation (intermittent pos-
itive pressure mechanical ventilation provided via a endotracheal
tube) (hours or days)
4) intraventricular haemorrhage and/or periventricular leucoma-
lacia (IVH/PVL)
5) survival to discharge
6) long term survival (to 24 months of age)
7) neurological and developmental outcome at 24 months of age
Search methods for identification of studies
Searcheswere undertakenofMEDLINE fromFebruary 2004back
to 1966 and the Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library, Issue 1, 2004) using the fol-
lowing terms:
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infant, newborn (explode) [MeSH heading],
acidosis [MeSH heading], acidaemia/acidemia [textwords],
sodium bicarbonate [MeSH heading],
THAM/tromethamine/Tris [textwords].
The title and abstract of each retrieved studywas examined to assess
eligibility. If there was uncertainty, the full paper was examined.
Data collection and analysis
Criteria and methods used to assess the methodological quality of
the trials were the standard methods of the Cochrane Collabora-
tion and the Neonatal Review Group.
Studies were assessed using the following key criteria: blinding of
randomisation, blinding of intervention, completeness of follow
up and blinding of outcome measurement. Data were extracted
independently by the reviewers. Differences were resolved by dis-
cussion and consensus of the reviewers. If necessary, investigators
were contacted for additional information or data.Weightedmean
differences (and 95% confidence intervals) were to be reported
for continuous variables such as duration of oxygen therapy. For
categorical outcomes such as mortality, the relative risk (and 95%
confidence intervals) and risk difference (and 95% confidence in-
tervals) were to be reported. We were to use a fixed effect model
for the meta-analysis.
R E S U L T S
Description of studies
See: Characteristics of excluded studies.
Five studies using sodium bicarbonate or THAM for correction
of acidosis in low birth weight infants were identified. None were
found to meet the criteria for inclusion in this review.
Sinclair 1968 randomised 20 infants with a birth weight of
1000-2500g to receive one of four different treatment combina-
tions which consisted of limited/unlimited environmental oxy-
gen, slow/rapid bicarbonate administration and assisted/self-ven-
tilation. Neonates admitted for the study had to be hypoxaemic
(pO2 <=75 in 50% headbox oxygen) and acidaemic (pH<=7.25
if under 4 hours of age but if older than 4 hours could be either.
This study was excluded because the included babies had a mixed
rather than a purely metabolic acidaemia.
Van Vliet 1973 enrolled 50 newborn infants with severe respira-
tory distress (clinical signs and symptoms, typical chest x-ray and
Pa O2<100 in 90 to 100% environmental oxygen) to receive ei-
ther sodium bicarbonate or THAM. Although acidaemia was not
necessary to be enrolled in the study, mean pH was 7.16. Method
of randomisation was not described. This study was excluded be-
cause of the unclear randomisation, enrolment of neonates with
birth weights >2500g and lack of acidaemia as an entry criteria for
the study.
Baum 1975 enrolled 19 neonates with severe respiratory distress
into a non-randomised study to receive either a rapid (<30 sec-
onds ) THAM injection or one of three sodium bicarbonate treat-
ments (injection over 30 seconds, 2 minutes or 5 minutes). Aci-
daemia was not an entry criterion. Other reasons for exclusion
were non-randomisation and enrolment of neonates with birth
weights >2500g.
Bland 1976 examined the effects of infusions of sodium bicarbon-
ate over 5 to 10 minutes as compared with infusions of glucose
or albumin in 51 hypoproteinaemic premature (<37 weeks ges-
tation) infants at risk of developing acidaemia. Acidaemia while
present in the majority of infants was not an essential prerequisite
for entry in this trial. This study was excluded because the infusion
of sodium bicarbonate was longer than 5 minutes and because of
the enrolment of newborn infants with birth weights >2500g.
Corbet 1977 studied the effects of a slow infusion of sodium bi-
carbonate in 62 acidaemic premature neonates with birth weights
<1500g as compared with no treatment. Acidaemia while present
in themajority of infants was not an essential prerequisite for entry
in this trial. This study was excluded because it compared a slow
infusion of sodium bicarbonate titrated to pH with no sodium
bicarbonate.
Risk of bias in included studies
No studies were found meeting the criteria for inclusion in this
review.
Effects of interventions
No studies were found meeting the criteria for inclusion in this
review.
D I S C U S S I O N
There are no randomised controlled trials to support or refute the
rapid correction of acidosis in LBW neonates with early metabolic
acidosis.
We asked a very specific question about the use of rapid correction
of metabolic acidosis, as opposed to slow or no correction, because
of the concerns with regard to rapid infusion of alkalising agents,
especially in LBW infants. Observational studies in human new-
born infants have reported an association between intraventricu-
lar haemorrhage and rapid injection of alkalising agents (Finberg
1977, Simmons 1974). This association is possibly due to the im-
mediate effects of an injection of alkali such as hypernatremia,
hyperosmolarity or alterations of cerebral blood flow.
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Studies on the immediate effects of an injection of sodium bicar-
bonate with hypernatremia and hyperosmolarity include:
1. Simmons et al (Simmons 1974) - a comparison of two dif-
ferent approaches to correction of metabolic acidosis in human
newborn infants with sodium bicarbonate in a retrospective re-
view. He found that intracranial haemorrhage was associated with
hypernatremia (>150 mEq/L) or excessive sodium administration
(>8 mEq/kg/d) in 81% of the cases.
2. Papile et al (Papile 1978), in an observational study on the effect
of sodium bicarbonate administration on intraventricular haem-
orrhage in very low birth weight infants, found no association be-
tween the serum sodium concentrations or amount of intravenous
sodium bicarbonate administered and the occurrence of intraven-
tricular haemorrhage. However they did find an association be-
tween a rapid infusion rate as well as high osmolarity of sodium
bicarbonate and intraventricular haemorrhage.
3. Finberg 1977 (Finberg 1977) also demonstrated that intraven-
tricular haemorrhage is associatedwith the high concentration and
rapid rate of infusion of sodium bicarbonate.
Others have investigated the immediate effects of an injection of
sodium bicarbonate on cerebral blood flow. These include:
1. Lou et al (Lou 1978), who found a reduction of cerebral blood
flow in human infants of up to 87% after variable doses of sodium
bicarbonate (between 1 and 8 mEq/kg).
2. Laptook (Laptook 1985), who examined the effects of a mod-
erate dose of sodium bicarbonate (2 mEq/kg infused over 3 min-
utes) on cerebral blood flow in a model using 1 day old piglets.
He found no effect of sodium bicarbonate on cerebral blood flow
or oxygen delivery if administered after hypoxia and acidaemia -
however the dose used did not result in any alteration in osmolality
or serum sodium concentrations.
Furthermore, other animal studies suggest there are other adverse
effects with the correction of acidosis with alkalising agents that
may be harmful to the LBW infant.
1. Steichen and Kleinman (Steichen 1977) found that an infusion
of sodium bicarbonate (2 mEq/kg infused over 3 minutes), in
newborn dogs with fixed ventilation, increased serum osmolality
and PaCO2.
2. Graf et al (Graf 1985) showed that treatment of hypoxic lactic
acidosis with sodium bicarbonate in dogs decreased cardiac output
and blood pressure (Graf 1985).
3. Bureau et al (Bureau 1980) showed that correction of metabolic
acidosis worsened cerebral hypoxia and cerebral acidaemia in dogs
(Bureau 1980).
The other agent used to correct metabolic acidosis, THAM, also
has concernswith regard to its use in sickLBWinfants. THAMcan
cause depression of ventilation and hypoglycaemia, and delivers an
even greater osmolar load than sodium bicarbonate (Heird 1972).
There are only two randomised controlled trials where alkali has
been compared with placebo or no treatment in human infants
who are acidaemic or at risk of acidaemia. A randomised trial
by Corbet et al (Corbet 1977) comparing slow correction of aci-
daemia with no correction in preterm infants showed no benefit
in terms of the rate of pH-correction, mortality or incidence of in-
traventricular haemorrhage. Bland et al (Bland 1976) performed a
randomised controlled trial comparing two doses of sodium bicar-
bonate with albumin or dextrose-water infused over 5-10 minutes
in infants at risk of acidaemia (hypoproteinaemic and less than 37
weeks gestation) within two hours of birth - there were no dif-
ferences in mortality, intracranial haemorrhage or the incidence
of respiratory distress syndrome. There was a trend to increased
mortality and incidence of intracranial haemorrhage in the groups
treated with sodium bicarbonate. There seems to be little available
evidence supporting the correction of metabolic acidaemia by any
means.
Because the effects of rapid injection of alkali, described above, can
have an effect on neurodevelopmental outcome these worrisome
reports should lead the clinician to caution. In the absence of any
evidence of benefit from the rapid injection of alkali it would be
difficult to justify its use in LBW infants with metabolic acidosis.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is no evidence available from randomised controlled trials
to support or refute the rapid correction of metabolic acidosis, in
LBW infants with metabolic acidosis in the first 24 hours of life,
as compared with slow or no correction.
Implications for research
If rapid correction is thought to be a useful treatment in the correc-
tion of metabolic acidaemia then there is a need for studies, with
a larger number of infants, to clarify whether there is any benefit
from this treatment without significant harm. However, given the
lack of evidence that any correction of metabolic acidaemia con-
fers significant benefit without harm, it would probably be pru-
dent to investigate whether any correction of metabolic acidaemia
is beneficial before studying rapid correction. Any studies investi-
gating the use of alkalising agents should include important clini-
cal outcomes such as ventilatory parameters, mortality, IVH/PVL
and neurodevelopmental outcome. Despite the apparent lack of
benefit or detriment of rapid correction of metabolic acidosis, the
potential hazards of this therapy should be appreciated. As cau-
tion is warranted as to the possibility of intraventricular bleeding
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after rapid injection of alkalising agents, this question may best be
answered in animal studies first.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Baum 1975 Not randomised; two forms of treatment compared with each other (THAM in ventilated infants, sodium bicar-
bonate for non-ventilated infants)
Bland 1976 Infants included were hypoproteinaemic and <37 weeks gestational age, no birthweight cut-off; trial compares slow
infusion with albumin and placebo
Corbet 1977 Comparison of slow infusion of sodium bicarbonate titrated to pH with no sodium bicarbonate
Sinclair 1968 The study participants did not all have “proven metabolic acidaemia (on arterial blood gas)” at enrolment into the
study
Van Vliet 1973 All babies with severe RDS were randomly treated with either sodium bicarbonate or THAM. Randomisation
method is unclear, method of application of initial dose of buffer not reported
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D A T A A N D A N A L Y S E S
This review has no analyses.
WH A T ’ S N E W
Last assessed as up-to-date: 11 March 2004.
Date Event Description
28 October 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 1, 2001
Review first published: Issue 1, 2002
Date Event Description
12 March 2004 New search has been performed This review updates the existing review of “Rapid cor-
rection of early metabolic acidaemia in comparison with
placebo, no intervention or slow correction in LBW in-
fants”, published in The Cochrane Library, Issue 1, 2002
(Kecskes 2002).
No new trials have been identified as a result of the most
recent search and no changes have been made to this re-
view
8 October 2001 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
ZBK - wrote the review, searched for references to include in the review, translated german, norwegian and french language articles,
assessed the methodological quality of the trials considered for this review.
MWD - revised and edited the review, searched for references to include in the review, assessed the methodological quality of the trials
considered for this review.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
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born; Sodium Bicarbonate [therapeutic use]; Tromethamine [therapeutic use]
MeSH check words
Humans
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